These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 21816781)
1. Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis. Wu VC; Lo SC; Chen YL; Huang PH; Tsai CT; Liang CJ; Kuo CC; Kuo YS; Lee BC; Wu EL; Lin YH; Sun YY; Lin SL; Chen JW; Lin SJ; Wu KD; J Clin Endocrinol Metab; 2011 Oct; 96(10):3175-83. PubMed ID: 21816781 [TBL] [Abstract][Full Text] [Related]
3. Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans. Thum T; Schmitter K; Fleissner F; Wiebking V; Dietrich B; Widder JD; Jazbutyte V; Hahner S; Ertl G; Bauersachs J Eur Heart J; 2011 May; 32(10):1275-86. PubMed ID: 20926363 [TBL] [Abstract][Full Text] [Related]
4. Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma. Lin YH; Lin LY; Chen A; Wu XM; Lee JK; Su TC; Wu VC; Chueh SC; Lin WC; Lo MT; Wang PC; Ho YL; Wu KD; Atherosclerosis; 2012 Mar; 221(1):154-9. PubMed ID: 22197109 [TBL] [Abstract][Full Text] [Related]
6. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003 [TBL] [Abstract][Full Text] [Related]
7. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Rossi GP; Bolognesi M; Rizzoni D; Seccia TM; Piva A; Porteri E; Tiberio GA; Giulini SM; Agabiti-Rosei E; Pessina AC Hypertension; 2008 May; 51(5):1366-71. PubMed ID: 18347224 [TBL] [Abstract][Full Text] [Related]
8. Time course and factors predicting arterial stiffness reversal in patients with aldosterone-producing adenoma after adrenalectomy: prospective study of 102 patients. Liao CW; Lin LY; Hung CS; Lin YT; Chang YY; Wang SM; Wu VC; Wu KD; Ho YL; Satoh F; Lin YH Sci Rep; 2016 Feb; 6():20862. PubMed ID: 26883298 [TBL] [Abstract][Full Text] [Related]
9. Adrenalectomy improves arterial stiffness in primary aldosteronism. Strauch B; Petrák O; Zelinka T; Wichterle D; Holaj R; Kasalický M; Safarík L; Rosa J; Widimský J Am J Hypertens; 2008 Oct; 21(10):1086-92. PubMed ID: 18654122 [TBL] [Abstract][Full Text] [Related]
10. Hypokalemia correlated with arterial stiffness but not microvascular endothelial function in patients with primary aldosteronism. Chang YY; Chen A; Chen YH; Hung CS; Wu VC; Wu XM; Lin YH; Ho YL; Wu KD; J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):353-9. PubMed ID: 25143326 [TBL] [Abstract][Full Text] [Related]
12. Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience. Sukor N; Gordon RD; Ku YK; Jones M; Stowasser M J Clin Endocrinol Metab; 2009 Jul; 94(7):2437-45. PubMed ID: 19401369 [TBL] [Abstract][Full Text] [Related]
13. Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism. Lin YH; Wu XM; Lee HH; Lee JK; Liu YC; Chang HW; Lin CY; Wu VC; Chueh SC; Lin LC; Lo MT; Ho YL; Wu KD; J Hypertens; 2012 Aug; 30(8):1606-13. PubMed ID: 22688266 [TBL] [Abstract][Full Text] [Related]
14. Adipokines and cardiometabolic profile in primary hyperaldosteronism. Iacobellis G; Petramala L; Cotesta D; Pergolini M; Zinnamosca L; Cianci R; De Toma G; Sciomer S; Letizia C J Clin Endocrinol Metab; 2010 May; 95(5):2391-8. PubMed ID: 20194710 [TBL] [Abstract][Full Text] [Related]
15. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas. Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567 [TBL] [Abstract][Full Text] [Related]
16. Primary aldosteronism -- screening, diagnosis and therapy. Horký K; Gregorová I; Vancura J; Silinková-Málková E; Hradec E Cor Vasa; 1981; 23(4):265-79. PubMed ID: 7028394 [TBL] [Abstract][Full Text] [Related]
17. Endothelial progenitor cells in patients with essential hypertension. Delva P; Degan M; Vallerio P; Arosio E; Minuz P; Amen G; Di Chio M; Lechi A J Hypertens; 2007 Jan; 25(1):127-32. PubMed ID: 17143183 [TBL] [Abstract][Full Text] [Related]
18. Hyperaldosteronism is associated with a decrease in number and altered growth factor expression of endothelial progenitor cells in rats. Ladage D; Schützeberg N; Dartsch T; Krausgrill B; Halbach M; Zobel C; Müller-Ehmsen J Int J Cardiol; 2011 Jun; 149(2):152-156. PubMed ID: 20116868 [TBL] [Abstract][Full Text] [Related]
19. [Number and function of circulating endothelial progenitor cell in diabetics with different vascular complications]. Chen LL; Liao YF; Zeng TS; Li YM; Yu F; Li HQ Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1234-9. PubMed ID: 19595175 [TBL] [Abstract][Full Text] [Related]
20. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma. ; Wu VC; Chueh SC; Chang HW; Lin LY; Liu KL; Lin YH; Ho YL; Lin WC; Wang SM; Huang KH; Hung KY; Kao TW; Lin SL; Yen RF; Chen YM; Hsieh BS; Wu KD Am J Kidney Dis; 2009 Oct; 54(4):665-73. PubMed ID: 19628318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]